FDA Modernization Act of 2021
Latest action · Apr 16, 2021 Referred to the Subcommittee on Health.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedApr 15, 2021
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
FDA Modernization Act of 2021
This bill allows an applicant for market approval for a new drug to use methods other than animal testing to establish the drug's safety and effectiveness. Under this bill, these alternative methods may include cell-based assays, organ chips and microphysiological systems, sophisticated computer modeling, and other human biology-based test methods.
Cosponsors 114
Members who signed on, in the order they did. Signatures ran from Apr 15, 2021 to Dec 1, 2022; 4 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-PA | Brendan F. Boyle | Original | Apr 15, 2021 |
| D-VA | Elaine G. Luria | Original | Apr 15, 2021 |
| D-NJ | Mikie Sherrill | Original | Apr 15, 2021 |
| R-SC | Nancy Mace | Original | Apr 15, 2021 |
| R-PA | Brian K. Fitzpatrick | May 20, 2021 | |
| R-OK | Tom Cole | May 20, 2021 | |
| R-TX | Pat Fallon | Jul 22, 2021 | |
| R-FL | Maria Elvira Salazar | Aug 13, 2021 | |
| D-CT | Rosa L. DeLauro | Aug 13, 2021 | |
| D-IL | Mike Quigley | Oct 22, 2021 | |
| D-OR | Peter A. DeFazio | Oct 22, 2021 | |
| D-CA | Ted Lieu | Oct 22, 2021 | |
| R-AL | Barry Moore | Nov 1, 2021 | |
| R-GA | Earl L. "Buddy" Carter | Nov 1, 2021 | |
| D-TX | Lizzie Fletcher | Nov 5, 2021 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Apr 15, 2021 |
| Health Subcommittee | Referred Apr 16, 2021 |
Actions 3
Everything that happened, newest first.
- Apr 16, 2021Referred to the Subcommittee on Health.
- Apr 15, 2021Introduced in House
- Apr 15, 2021Referred to the House Committee on Energy and Commerce.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 167, no. 65, April 15, 2021, page H1843.
Printed hearings 1
Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.
| Number | Hearing | Committee | Held |
|---|---|---|---|
| Serial No. 117-75 | THE FUTURE OF MEDICINE: LEGISLATION TO ENCOURAGE INNOVATION AND IMPROVE OVERSIGHT308 pages | Energy and Commerce Committee | Mar 17, 2022 |
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| HR 7667 | Food and Drug Amendments of 2022 | Related bill | Jun 9, 2022 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend the Federal Food, Drug, and Cosmetic Act to allow manufacturers and sponsors of a drug to use alternative testing methods to animal testing to investigate the safety and effectiveness of a drug, and for other purposes.
- Short Title(s) as Introduced
- FDA Modernization Act of 2021
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- Apr 15, 2021Introduced in House
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.